We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

The Association Between Overweight and Oocyte Diameter in Women Undergoing Vitro Fertilization

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2012 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
ClinicalTrials.gov Identifier:
First Posted: August 27, 2012
Last Update Posted: August 27, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Hillel Yaffe Medical Center
We believe that there is an association between BMI and oocyte diameter in women undergoing IVF treatments. We plan to measure the oocyte diameter in 2 groups of women undergoing IVF. One group will have BMI 20-25 and the other group will have BMI above 30.

Condition Intervention
Infertility Obesity Other: Oocyte Measurement

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • Larger Size of Oocyte Diameter [ Time Frame: One year ]
    Oocyte will be measured in women undergoing IVF treatment

Estimated Enrollment: 60
Study Start Date: September 2012
Estimated Study Completion Date: September 2013
Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
BMI over 30
Women undergoing IVF with BMI over 30
Other: Oocyte Measurement
BMI 20-25
Women undergoing IVF treatments with BMI between 20-25
Other: Oocyte Measurement


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Women undergoing IVF treatments

Inclusion Criteria:

  • IVF treated patients
  • BMI between 20-25 or over 30

Exclusion Criteria:

  • Everyone else
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01672931

Contact: Gai Shrem, MD 972-50-6793080 gai.shrem@gmail.com

Hillel Yaffe Medical Center Not yet recruiting
Hadera, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center
Principal Investigator: Gai Shrem, MD Hillel Yaffe Medical Center
  More Information

Responsible Party: Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT01672931     History of Changes
Other Study ID Numbers: 0034-12 HYMC
First Submitted: August 22, 2012
First Posted: August 27, 2012
Last Update Posted: August 27, 2012
Last Verified: August 2012

Additional relevant MeSH terms:
Genital Diseases, Male
Genital Diseases, Female